Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy

B. Ji, N. Lounis, C. Truffot-Pernot, J. Grosset

Research output: Contribution to journalComment/debatepeer-review

Abstract

Beige mice were inoculated intravenously with 107.90 CFU of Mycobacterium avium 101. Among the untreated control mice, when the mean CFU per spleen increased to a level greater than 108, small numbers of organisms resistant to clarithromycin (CLARI) were isolated from some of the spleens; the frequency of CLARI-resistant mutants was estimated to be between 10-8 and 10-9. In mice treated with 200 mg of CLARI per kg of body weight six times weekly, however, CLARI-resistant organisms were isolated from the spleens of all mice examined after treatment for 8 weeks; the mean CFU per spleen and the frequency of resistant mutants were significantly greater than those of control mice and increased further after treatment for 16 weeks. The MICs of CLARI against the resistant organisms isolated from both control and treated mice were ≥512 μg/ml.

Original languageEnglish (US)
Pages (from-to)2839-2840
Number of pages2
JournalAntimicrobial agents and chemotherapy
Volume36
Issue number12
DOIs
StatePublished - 1992

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Selection of resistant mutants of Mycobacterium avium in beige mice by clarithromycin monotherapy'. Together they form a unique fingerprint.

Cite this